Gastroenterology Activities
The Evolution of Immune Checkpoint Inhibitors in the Treatment of GI Cancers and the Pharmacist's Growing Role
0290-0000-20-157-H01-P
This activity will review biomarkers useful for predicting patient response to immune checkpoint inhibitors and techniques for adherence monitoring will also be addressed to assist pharmacists in developing strategies to optimize the care and management of patients with GI cancers.
1.50
Hereditary Angioedema: Outlining the Differences Between Current and Emerging Therapies
0290-0000-20-139-H01-P
This activity will equip pharmacists with the knowledge necessary to educate and counsel patients on appropriate medication use for effective and safe management of HAE attacks.
1.50
Inflammatory Bowel Disease: A Panel Discussion on Clinical and Operational Strategies for Biologic Usage
0290-0000-20-134-H01-P
This expert panel discussion will highlight strategies for managing IBD as well as review recently approved agents, updated treatment guidelines, recent clinical trial data on biologics and biosimilars, and real-world data on how specialty pharmacists are helping to manage this complex disease.
1.50
Hereditary Angioedema: Management Updates for the Specialty Pharmacist
0290-0000-20-113-H01-P
This CE article will characterize the diagnosis and background of hereditary angioedema (HAE) and the significance of early intervention.
2.00